Modern Slavery Statement 2019/20


This statement is made pursuant to section 54 of the Modern Slavery Act 2015. It constitutes Cancer Research UK’s (CRUK) slavery and human trafficking statement for the financial year ended 31 March 2020. Of our wholly-owned subsidiaries, this statement covers the activities of Cancer Research UK Trading Limited and Cancer Research Technology Limited, which procure goods and services from and form part of CRUK’s supply chain. 

Our Organisation 

CRUK is the world’s leading cancer charity dedicated to saving lives through research, influence and information. We rely on the generosity of the public to fund this research through donations, buying goods in our shops or online and taking part in a wide range of fundraising events. 

We have around 4,000 staff and over 40,000 volunteers, most of whom are based in the United Kingdom. Our staff are largely directly employed and aren’t generally in any category which is seen to be vulnerable to modern slavery in this country, so ourmain focus is to ensure there are policies and due diligence procedures in place for relevant suppliers. 

Our Supply Chain 

At CRUK we’re committed to continuously improving our practices to identify and eliminate any slavery and human trafficking inour business and supply chains, and to acting ethically and with integrity in all our business relationships. 

We use a wide range of suppliers who supply goods for sale, provide services at events and support our operations. 


We have a number of policies which underpin our approach to tackling the risk of modern slavery in our supply chains. These include our: 

  • Working with Suppliers and Partners Policy which sets out internal requirements for buying goods and services; 

  • Responsible Procurement Policy which sets out our position on issues of human rights, child and forced labour and modern slavery; 

  • Whistleblowing Policy which encourages staff and volunteers to report concerns including any related to modern slaverytrafficking and child or forced labour; and 

  • Safeguarding Policy which sets out our approach to safeguarding and the actions that staff are required to take in dealing with safeguarding concerns. 

Due Diligence 

We continuously review and seek to mitigate risks in relation to suppliers who operate in areas where there may be modern slavery risks in the supply chain. This includes those who support the procurement of goods and materials for our fundraising and marketing activities and for sale in our network of charity shops, particularly where those goods and materials are acquired from suppliers in high risk countries. We have a dedicated cross-functional organisational working group to support our work. 

 the last year we’ve:  

  • Improved the supplier onboarding process;  
  • Worked to update the modern slavery related provisions in our high-risk supplier contracts;  
  • Carried out an internal audit of our modern slavery due diligence processes and started to implement the recommendations; and  
  • Worked with a global auditing consultancy to advise on current processes and provide recommendations for improvements 

We require the following from all suppliers we class as high risk:  

  • Completion of our Modern Slavery Due Diligence Questionnaire by our direct suppliers. This Questionnairecovers their governance, policies, training and supply chain management processes; and 
  • Manufacturing sites to be members of either SEDEX or BSCI and to provide us with access to theirindependent ethical audits via the one of these platforms 

These are 
then evaluated by our Corporate Social Responsibility team. 

SEDEX is a Supplier Ethical Data Exchange and BSCI is the Business Social Compliance Initiative  We are members of both. The SEDEX and BSCI platforms allow us to access audited information uploaded by manufacturing sites used by our suppliers, giving us a better insight into their supply chains. 

Whilst we are mindful of the limitations of independent ethical audits, we think these audits are an effective tool for assessing modern slavery risks. 

Should a supplier or manufacturing site fail to provide the information requested or to meet our expectations, we will take appropriate action. This may include not entering into a relationship or suspending/terminating our relationship with a supplier or asking a supplier not to procure goods from a particular manufacturing site. 

Training & Advice 

During the year, we have continued to provide advice and guidance to those teams who have direct responsibility for relevant supply chains and to build awareness of modern slavery risk across our core teams. 

Looking Ahead 

We will further enhance our procedures to help us identify, prevent and mitigate any risks of modern slavery or human trafficking in relation to new and existing suppliers and in relation to our own operations. 


This statement has been formally approved by the Trustees of Cancer Research UK and the Directors of Cancer Research UK Trading Limited and signed on their behalf. 

Professor Sir Leszek Borysiewicz 
Cancer Research UK